Seeking Alpha

PrCABTREOTM (clindamycin phosphate, adapalene and benzoyl peroxide gel) Treatment for Acne Vulgaris Receives Positive Reimbursement Recommendations from Canada's Drug Agency ...

LAVAL, QC / ACCESSWIRE / November 18, 2024 / Bausch Health (BHC:CA), Canada Inc., part of Bausch Health Companies Inc., today announced that Pr CABTREO TM (clindamycin phosphate, adapalene and benzoyl ...
Nasdaq

CABTREO(TM) (clindamycin phosphate, adapalene and benzoyl peroxide) Topical Gel for the Treatment of Acne Vulgaris Now Available in the U.S.

LAVAL, QC / ACCESSWIRE / January 30, 2024 / Bausch Health Companies Inc. (NYSE:BHC)(TSX:BHC) and its dermatology business, Ortho Dermatologics, today announced the U.S. launch of CABTREO™ (clindamycin ...
Nasdaq

FDA Approves Cabtreo(TM) (Clindamycin Phosphate, Adapalene and Benzoyl Peroxide) Topical Gel for the Treatment of Acne Vulgaris in Patients Twelve Years of Age and Older

LAVAL, QC / ACCESSWIRE / October 20, 2023 / Bausch Health Companies Inc. (NYSE:BHC) (TSX:BHC) ("Bausch Health") and its dermatology business, Ortho Dermatologics, today announced that the U.S. Food ...
Healio

Benzoyl peroxide 3% plus clindamycin 1% demonstrated significant acne lesion reduction

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. Stiefel announced in a press release results of a German ...